Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2010
06/10/2010WO2010063721A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010WO2010063666A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010WO2010063663A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063662A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010032875A3 Heterocyclic carboxamide compounds
06/10/2010WO2010025370A3 Preparation of ranolazine
06/10/2010WO2009122430A3 Novel crystalline forms of desloratadine and process for preparing the same
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145070 Anti-cancer compound and manufacturing method thereof
06/10/2010US20100145061 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2h-pyrrol-5-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
06/10/2010US20100145060 Schwartz Reagents: Methods of In Situ Generation and Use
06/10/2010US20100145059 Method for producing hydrazine compound,and production intermediates of hydrazine compound and methods of producing the intermediates
06/10/2010US20100145058 Barium salt of benzimidazole derivative
06/10/2010US20100145057 Novel prodrugs
06/10/2010US20100145054 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145047 Inhibitors of diacylglycerol acyltransferase
06/10/2010US20100145042 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144796 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino- methyl)-phenylamino]-methyl-1-methyl-1h-benzimidazole-5-carbonyl) -pyridin-2-yl-amino]-propionate
06/10/2010US20100144793 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
06/10/2010US20100144789 1-Isopropyl-2-Oxo-1,2-dihydropyridine-3-carboxamide Derivatives having 5-HT4 Receptor Agonistic Activity
06/10/2010US20100144771 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
06/10/2010US20100144770 Pyrimidinones as Casein Kinase II (CK2) Modulators
06/10/2010US20100144766 Composition and method for treating or preventing skeletal muscle fibrosis
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144762 Novel sulfonamides as l-cpt1 inhibitors
06/10/2010US20100144760 Novel compounds
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144752 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144741 Ethanolamine derivatives useful as bace inhibitors
06/10/2010US20100144734 1, 2, 3-Triazole derivatives as new cannabinoid-1 receptor antagonists
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144724 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010US20100144723 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/10/2010US20100144721 Inhibitors of c-met and uses thereof
06/10/2010US20100144720 Inhibitors of human tumor-expressed ccxckr2
06/10/2010US20100144716 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100144710 Piperazine and Piperidine MGLUR5 Potentiators
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144701 Modulators of CB1 Receptors
06/10/2010US20100144699 Combination Medicaments for Treating Bacterial Infections
06/10/2010US20100144697 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144696 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144695 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/10/2010US20100143917 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100141122 Oled device with cyclobutene electron injection materials
06/10/2010US20100140603 Blue light emitting compound and organic light emitting diode device comprising the same
06/10/2010CA2745433A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745420A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010CA2745252A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010CA2745019A1 Quinolone compound and pharmaceutical composition
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/10/2010CA2744962A1 Antibacterial compounds
06/10/2010CA2744914A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2744300A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/10/2010CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/09/2010EP2194049A1 N-oxides of N-phenyl-2-pyrimidine-amine derivatives
06/09/2010EP2194048A1 Nitrate esters for the treatment of vascular and metabolic diseases
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP2193119A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
06/09/2010EP2097374B1 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
06/09/2010EP1999126B1 Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
06/09/2010EP1730115B1 5-aminoalkylpyrazole derivatives as pesticidal agents
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1910173B Indolylmaleimide derivatives as PKC inhibitors
06/09/2010CN1863789B Substituted isoquinolinones
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1735607B 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
06/09/2010CN1696115B Synthesized building block of derivative of 4-substituent-4-amido-piperidine, preparation method and application
06/09/2010CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them
06/09/2010CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors
06/09/2010CN101730691A Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
06/09/2010CN101730690A Sulfonamide compound, and crystal thereof
06/09/2010CN101730686A Piperazine compounds with herbicidal action
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723935A 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof
06/09/2010CN101723934A Method for refining fasudil hydrochloride
06/09/2010CN101723933A Piperidine-4-ketone-O-substituted oxime triadimenol-type antifungal compound and preparation method thereof
06/09/2010CN101723932A Nitropyridine ethylenimine compound, medicinal composition, preparation method and application thereof
06/09/2010CN101723911A Method for synthesizing N-aryl-1,3-oxazolin-2-one compounds
06/09/2010CN101723907A O-dicyano-acenaphtho pyrazine compound and anti-tumor application thereof
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101723894A N-quinoline amide derivatives and preparation method and application thereof
06/09/2010CN101723890A Aryl thiourea and preparation method and application thereof
06/08/2010US7732628 Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis
06/08/2010US7732601 salt formation in solvent; inoculation
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 1080